Zhong-Li Zheng

Title: Innovations of Zhong-Li Zheng

Introduction

Zhong-Li Zheng is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of immunoinflammatory disease treatment through his innovative work. With a total of 2 patents, Zheng's inventions focus on the development of cyclic peptides that have the potential to revolutionize therapeutic approaches.

Latest Patents

Zhong-Li Zheng's latest patents include the invention of cyclic CS-1 peptidomimetics, which are designed to inhibit the binding between the VLA-4 receptor on inflammatory leukocytes and the fibronectin CS-1 peptide on endothelial cells. This binding inhibition is crucial for addressing various immunoinflammatory disease states. The patents also disclose pharmaceutical compositions that utilize these cyclic peptides and outline processes for treating immunoinflammatory conditions effectively.

Career Highlights

Zhong-Li Zheng is currently associated with Cytel Corporation, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on medical treatments and patient outcomes.

Collaborations

Zheng collaborates with esteemed colleagues such as Thomas S Arrhenius and Anna Tempczyk, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Zhong-Li Zheng's contributions to the field of immunoinflammatory disease treatment through his patented inventions highlight his role as a leading inventor. His work at Cytel Corporation and collaborations with other professionals further enhance the potential for impactful medical advancements.